Interestingly, CARMA2−/− mice are resistant to psoriasis provoked by intraperitoneal injection of recombinant IL-23 or treatment with imiquimod (IMQ) cream, an agonist of TLR7/TLR9. Here, IL23A is linked to psoriasis.